CORONA, Calif., May 23 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson’s president and chief executive officer, will provide an overview and update of the Company’s business at the UBS Global Specialty and Generic Pharmaceuticals Conference on Wednesday, May 28, 2008 at 2:30 p.m. London BST (9:30 a.m. EDT).
This presentation will be webcast live and can be accessed on Watson Pharmaceuticals’ Investor Relations Web site at http://ir.watson.com. The webcast can also be accessed at the following URL: http://events.webeventservices.com/ubs/2008/05/28/index.asp.
An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc, headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.
For press releases and other company information, visit Watson Pharmaceuticals’ Web site at http://www.watson.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)
CONTACT: Patty Eisenhaur of Watson Pharmaceuticals, Inc., +1-951-493-5611
Web site: http://www.watson.com/
